HDAC9 and cancer: As expected, interference with DDR pathways by ATMi AZD1390 sensitized cancer cells to ionizing radiation, whereas p38i showed a weaker radiosensitizing effect than HDAC inhibitor, which showed the synergistic effect with 225Ac-PP-F11N.